Healthcare
M6P Therapeutics
Recorded September 17, 2024
M6P has developed a breakthrough technology that is driving the development of next generation enzyme replacement therapies.
M6P has developed a breakthrough technology that is driving the development of next generation enzyme replacement therapies.
How EpiQuest [NASDAQ: EEIQ], is profitingby making a North American higher education accessibleto the world.
Sigyn Therapeutics has developed patented devices that improve the performance of drugs that treat cancer.
Deep sea nodule collection provides higher quality critical minerals with significantly lower environmental impact than traditional mining.
Rally has built an asset-lite, dynamic, intercity transportation network, helping to fill the $5B worth of bus seats that go unsold every year
Caliber Company [NASDAQ: CWD] and PURE Pickleball are building the largest indoor pickleball facility in the world
M6P has developed a breakthrough technology that is driving the development of next generation enzyme replacement therapies.
An anti-inflammation platform that has the potential to treat Parkinson’s, Alzheimer’s, Liver disease, Diabetes, Arthritis and more.
Mitra Chem is creating a sustainable, North American battery materials supply chain to electrify transportation and energy storage.
IDC Ventures backs industry-defining founders from series A to growth stages across Europe, The U.S. and Latin America.
Repair Bio has developed a cholesterol degrading platform that has the potential to reverse atherosclerosis and many other diseases
An anti-inflammation platform that has the potential to treat Parkinson’s, Alzheimer’s, Liver disease, Diabetes, Arthritis and more.